Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Feb 28, 2025
Product Development
Caribou: Solving the allogeneic problem with CRISPR
Caribou selected a de-risked target and modality to take on multiplexed editing
Read More
BioCentury
|
Feb 9, 2022
Discovery & Translation
Translational trendspotting: a Distillery dive into infectious disease
Host targets, cross-reactive mAbs and COVID-19 countermeasures stand out in BioCentury’s Distillery
Read More
BioCentury
|
Jul 29, 2021
Distillery Therapeutics
Pan-caspase inhibitor identified for bacterial skin infections
DISEASE CATEGORY: Infectious disease
INDICATION: Staphylococcus; Streptococcus; Pseudomonas A team at Johns Hopkins University School of Medicine showed a pan-caspase inhibitor could treat
Read More
BioCentury
|
Jun 23, 2020
Distillery Therapeutics
Overexpressing OXCT1-AS1, a long non-coding RNA, for heart attacks
Read More
BioCentury
|
Mar 21, 2019
Clinical News
Conatus sinks after NASH therapy misses fibrosis endpoint
Read More
BioCentury
|
Dec 6, 2018
Clinical News
Conatus' emricasan misses in Phase IIb for NASH cirrhosis
Read More
BioCentury
|
Dec 6, 2018
Clinical News
Conatus down on Phase IIb NASH miss
Read More
BioCentury
|
Sep 14, 2018
Preclinical News
UCSD researchers identify mechanism, target in NASH
Read More
BioCentury
|
Apr 6, 2018
Clinical News
Conatus' emricasan misses in Phase IIb in liver transplant patients
Read More
BioCentury
|
Apr 5, 2018
Clinical News
Conatus falls as emricasan misses in liver transplant patients
Read More
Items per page:
10
1 - 10 of 122
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help